Search results

Order by most recent / most popular / relevance

Results: 1-10 of 25

CMS releases list of teaching hospitals; educational efforts and requests for additional clarification regarding the physician payment sunshine final rule continue

Reed Smith LLP
-
USA
-
May 3 2013

In preparation for data collection to begin under the Physician Payment Sunshine Act Final Rule on August 1, 2013, the Centers for Medicare &

OIG views PODs as "inherently suspect" under the anti-kickback statute

Reed Smith LLP
-
USA
-
March 26 2013

Referencing what it deems a "proliferation" of physician-owned distributors (PODs), on March 26, 2013, the Department of Health and Human Services

The Sunshine Physician Payment Final Rule overview and analysis

Reed Smith LLP
-
USA
-
March 5 2013

On February 1, 2013, the Centers for Medicare & Medicaid Services (CMS) of the Department of Health and Human Services (HHS) released the

CMS releases Physician Payments Sunshine Act Final Rule

Reed Smith LLP
-
USA
-
February 1 2013

The Centers for Medicare & Medicaid Services (CMS) released late today its final rule implementing the physician payment transparency provisions of

Massachusetts releases final regulations, restores annual "Sunshine" reporting requirement for drugdevice manufacturers

Reed Smith LLP
-
USA
-
November 27 2012

On Wednesday, November 21, 2012, Massachusetts’ Public Health Council (“Council”) approved amendments to the State’s Marketing Code of Conduct, which restricts certain gifts and payments by pharmaceutical and medical device manufacturers to Massachusetts health care practitioners (“HCPs”) and requires disclosure of payments and transfers of value to HCPs

Massachusetts signals potential elimination of HCP payment reporting requirement through emergency regulatory amendments

Reed Smith LLP
-
USA
-
November 1 2012

On September 19, 2012, the Massachusetts Public Health Council approved emergency amendments to the State’s Marketing Code of Conduct regulations, 105 CMR 970.000, which restrict certain gifts and payments by pharmaceutical and medical device manufacturers to Massachusetts health care practitioners (“HCPs”) and require disclosure of payments and transfers of value to HCPs

As federal sunshine looms, massachusetts loosens manufacturer gift ban and disclosure law, and allows certain drug coupons and vouchers

Reed Smith LLP
-
USA
-
July 16 2012

As drug and device manufacturers continue to await final regulations and subsequent implementation of the federal Physician Payment Sunshine Act, passed as part of the Affordable Care Act, Massachusetts has relaxed its similar state law banning the provision by manufacturers of gifts to health care practitioners (“HCPs”) and requiring disclosure of payments and transfers of value to HCPs

CMS announces data collection for the Physician Payments Sunshine Act will not be required before 2013

Reed Smith LLP
-
USA
-
May 4 2012

This post was written by Elizabeth Carder-Thompson, Katie C

New Hampshire State Senate hearing on prohibition of certain physician relationships with medical device companies

Reed Smith LLP
-
USA
-
May 3 2012

The New Hampshire State Senate held a hearing on April 19, 2012 regarding HB 1725, a new measure that would prohibit all health care practitioners from prescribing or referring any U.S. Food and Drug Administration class II or class III implantable medical device if the practitioner stands to “profit indirectly or directly from the sale of the medical device by any supplier in which the health care practitioner has a direct or indirect ownership interest.”

New Hampshire quietly considers prohibition of physician relationships with medical device companies

Reed Smith LLP
-
USA
-
April 17 2012

On March 29, 2012, the New Hampshire House of Representatives recommended for passage HB 1725

next >